GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ARQ-751 | GLXC-26917
Compound class:
Synthetic organic
Comment: Vevorisertib (GLXC-26917, and formerly ARQ-751) is an allosteric, pan-AKT inhibitor that was designed for anti-tumour potential. The vevorisertib programme was terminated (for business reasons).
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| N-[1-[3-[3-[4-(1-aminocyclobutyl)phenyl]-2-(2-aminopyridin-3-yl)imidazo[4,5-b]pyridin-5-yl]phenyl]piperidin-4-yl]-N-methylacetamide |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11383 | vevorisertib |
Synonyms ![]() |
| ARQ-751 | GLXC-26917 |
Database Links ![]() |
|
| CAS Registry No. | 1416775-46-6 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL4802156 |
| GtoPdb PubChem SID | 479821403 |
| PubChem CID | 71138858 |
| Search Google for chemical match using the InChIKey | NZDSLYATTDIDPH-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | NZDSLYATTDIDPH |
| Search PubMed clinical trials | vevorisertib |
| Search PubMed titles | vevorisertib |
| Search PubMed titles/abstracts | vevorisertib |
| UniChem Compound Search for chemical match using the InChIKey | NZDSLYATTDIDPH-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | NZDSLYATTDIDPH-UHFFFAOYSA-N |